Clinical Trials Browser

Observational × capmatinib × 1 year × Clear all

NCT05703516 2026-06-01

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04575025 2025-09-15

Special Drug Use-results Surveillance of Tabrecta Tablets

Carcinoma, Non-Small-Cell Lung